CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net income (loss)	$ (243,966)	$ 2,205	$ (248,653)	$ 8,029
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	31,463	32,141	62,620	63,839
Non-cash interest expense	729	0	729	0
Benefit from deferred income taxes	(47,451)	0	(47,451)	0
Stock-based compensation expense	1,897	0	1,897	0
Impairment of long-lived assets and goodwill	250,400	0	250,400	0
Non-cash changes in self-insurance reserves	5,418	0	5,418	0
Other non-cash income, net	(33)	(1,137)	(587)	(1,508)
Changes in operating assets and liabilities, net of acquisitions:
Patient accounts receivable, net	4,911	17,642	(7,211)	16,830
Due to and due from third-party payors, net	(4,745)	17,218	5,355	1,748
Inventories, prepaid expenses and other current assets	5,103	4,127	2,277	7,585
Accounts payable and accrued liabilities	33,234	(16,073)	36,074	(73,902)
Long-term assets and liabilities, net	(164)	223	325	75
Net cash provided by operating activities	36,796	56,346	61,193	22,696
Cash flows from investing activities:
Capital expenditures for property and equipment	(20,367)	(10,471)	(33,207)	(20,410)
Capital expenditures for software	(1,278)	(1,664)	(3,804)	(2,661)
Acquisitions, net of cash acquired	0	(2,012)	0	(2,012)
Proceeds from sales of property and equipment	0	2,917	858	3,017
Other investing activities	492	(1,867)	544	(3,292)
Net cash used in investing activities	(21,153)	(13,097)	(35,609)	(25,358)
Cash flows from financing activities:
Borrowings of long-term debt	1,255,500	75	1,255,520	135
Repayments of long-term debt	(3,188)	(340)	(4,277)	(736)
Increase (decrease) in Due to Parent, net	31,669	(42,939)	25,183	9,261
Increase (decrease) in receivables facility, net	0	(2,854)	0	(5,187)
Payments of debt issuance costs	(28,003)	0	(28,003)	0
Cash paid to Parent in spin-off transaction	(1,217,336)	0	(1,217,336)	0
Cancellation of restricted stock awards for payroll tax withholdings on vesting shares	27	0	27	0
Cash distributions to noncontrolling investors	(163)	(1,292)	(2,647)	(1,422)
Purchases of shares from noncontrolling investors	0	(722)	(12)	(722)
Net cash provided by (used in) financing activities	38,506	(48,072)	28,455	1,329
Net change in cash and cash equivalents	54,149	(4,823)	54,039	(1,333)
Cash and cash equivalents at beginning of period	996	6,049	1,106	2,559
Cash and cash equivalents at end of period	55,145	1,226	55,145	1,226
Supplemental cash flow information:
Interest payments, net	8,894	23,828	36,347	49,630
Income tax payments, net of refunds (after spin-off transaction)	$ 34	$ 0	$ 34	$ 0